A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex
Stephen P Myers1, Joan O'Connor1, J Helen Fitton2, Lyndon Brooks3, Margaret Rolfe3, Paul Connellan4, Hans Wohlmuth4,5, Phil A Cheras1, Carol Morris41NatMed-Research Unit, Research Cluster for Health and Wellbeing, Southern Cross University, Lismore, NSW, Australia; 2Marinova Pty Ltd, Cam...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/c6c91163268e4150957e3d38914455f4 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:c6c91163268e4150957e3d38914455f4 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:c6c91163268e4150957e3d38914455f42021-12-02T02:28:17ZA combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex1177-54751177-5491https://doaj.org/article/c6c91163268e4150957e3d38914455f42011-02-01T00:00:00Zhttp://www.dovepress.com/a-combined-phase-i-and-ii-open-label-study-on-the-immunomodulatory-eff-a6351https://doaj.org/toc/1177-5475https://doaj.org/toc/1177-5491Stephen P Myers1, Joan O'Connor1, J Helen Fitton2, Lyndon Brooks3, Margaret Rolfe3, Paul Connellan4, Hans Wohlmuth4,5, Phil A Cheras1, Carol Morris41NatMed-Research Unit, Research Cluster for Health and Wellbeing, Southern Cross University, Lismore, NSW, Australia; 2Marinova Pty Ltd, Cambridge, TAS, Australia; 3Graduate Research College, Southern Cross University, Lismore, NSW, Australia; 4Centre for Phytochemistry and Pharmacology, Southern Cross University, Lismore, NSW, Australia; 5Medicinal Plant Herbarium, Southern Cross University, Lismore, NSW, AustraliaBackground: Isolated fucoidans from brown marine algae have been shown to have a range of immune-modulating effects. This exploratory study aimed to determine whether a seaweed nutrient complex containing a blend of extracts from three different species of brown algae plus nutrients is safe to administer and has biological potential as an immune modulator. The study was undertaken as an open-label combined Phase I and II study.Methods: Participants (n = 10) were randomized to receive the study medication at either a 100 mg (n = 5) or 1000 mg (n = 5) dose over 4 weeks. The primary outcome measurement was in vivo changes in lymphocyte subsets. The secondary outcome measures were ex vivo changes in T-lymphocyte (CD4 and CD8) activation, phagocytosis of granulocytes and monocytes, T helper 1/T helper 2 cytokines, and serum oxygen radical absorbance capacity.Results: The preparation was found to be safe over the 4 weeks at both doses tested. There were no clinically relevant changes to blood measurements of hemopoietic, hepatic, or renal function. Immunomodulatory measurements showed no dose response between the two doses. The combined results from the two doses demonstrated a significant increase in cytotoxic T cell numbers and phagocytic capacity in monocytes, and a significant decrease in levels of the inflammatory cytokine interleukin 6. A separate analysis of the 100 mg dose (n = 5) alone showed a significant linear component over time (P < 0.05) for phagocytosis by both granulocytes and monocytes.Conclusion: The seaweed nutrient complex was safe to use when taken orally over 4 weeks. The preparation was demonstrated to have potential as an immune modulator, and this bioactivity deserves further exploration.Keywords: seaweed, fucoidan, immune system, complementary medicine, nutraceutical Stephen P MyersJoan O'ConnorJ Helen Fittonet alDove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2011, Iss default, Pp 45-60 (2011) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Stephen P Myers Joan O'Connor J Helen Fitton et al A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex |
| description |
Stephen P Myers1, Joan O'Connor1, J Helen Fitton2, Lyndon Brooks3, Margaret Rolfe3, Paul Connellan4, Hans Wohlmuth4,5, Phil A Cheras1, Carol Morris41NatMed-Research Unit, Research Cluster for Health and Wellbeing, Southern Cross University, Lismore, NSW, Australia; 2Marinova Pty Ltd, Cambridge, TAS, Australia; 3Graduate Research College, Southern Cross University, Lismore, NSW, Australia; 4Centre for Phytochemistry and Pharmacology, Southern Cross University, Lismore, NSW, Australia; 5Medicinal Plant Herbarium, Southern Cross University, Lismore, NSW, AustraliaBackground: Isolated fucoidans from brown marine algae have been shown to have a range of immune-modulating effects. This exploratory study aimed to determine whether a seaweed nutrient complex containing a blend of extracts from three different species of brown algae plus nutrients is safe to administer and has biological potential as an immune modulator. The study was undertaken as an open-label combined Phase I and II study.Methods: Participants (n = 10) were randomized to receive the study medication at either a 100 mg (n = 5) or 1000 mg (n = 5) dose over 4 weeks. The primary outcome measurement was in vivo changes in lymphocyte subsets. The secondary outcome measures were ex vivo changes in T-lymphocyte (CD4 and CD8) activation, phagocytosis of granulocytes and monocytes, T helper 1/T helper 2 cytokines, and serum oxygen radical absorbance capacity.Results: The preparation was found to be safe over the 4 weeks at both doses tested. There were no clinically relevant changes to blood measurements of hemopoietic, hepatic, or renal function. Immunomodulatory measurements showed no dose response between the two doses. The combined results from the two doses demonstrated a significant increase in cytotoxic T cell numbers and phagocytic capacity in monocytes, and a significant decrease in levels of the inflammatory cytokine interleukin 6. A separate analysis of the 100 mg dose (n = 5) alone showed a significant linear component over time (P < 0.05) for phagocytosis by both granulocytes and monocytes.Conclusion: The seaweed nutrient complex was safe to use when taken orally over 4 weeks. The preparation was demonstrated to have potential as an immune modulator, and this bioactivity deserves further exploration.Keywords: seaweed, fucoidan, immune system, complementary medicine, nutraceutical |
| format |
article |
| author |
Stephen P Myers Joan O'Connor J Helen Fitton et al |
| author_facet |
Stephen P Myers Joan O'Connor J Helen Fitton et al |
| author_sort |
Stephen P Myers |
| title |
A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex |
| title_short |
A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex |
| title_full |
A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex |
| title_fullStr |
A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex |
| title_full_unstemmed |
A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex |
| title_sort |
combined phase i and ii open-label study on the immunomodulatory effects of seaweed extract nutrient complex |
| publisher |
Dove Medical Press |
| publishDate |
2011 |
| url |
https://doaj.org/article/c6c91163268e4150957e3d38914455f4 |
| work_keys_str_mv |
AT stephenpmyers acombinedphaseiandiiopenlabelstudyontheimmunomodulatoryeffectsofseaweedextractnutrientcomplex AT joanoamp39connor acombinedphaseiandiiopenlabelstudyontheimmunomodulatoryeffectsofseaweedextractnutrientcomplex AT jhelenfitton acombinedphaseiandiiopenlabelstudyontheimmunomodulatoryeffectsofseaweedextractnutrientcomplex AT etal acombinedphaseiandiiopenlabelstudyontheimmunomodulatoryeffectsofseaweedextractnutrientcomplex AT stephenpmyers combinedphaseiandiiopenlabelstudyontheimmunomodulatoryeffectsofseaweedextractnutrientcomplex AT joanoamp39connor combinedphaseiandiiopenlabelstudyontheimmunomodulatoryeffectsofseaweedextractnutrientcomplex AT jhelenfitton combinedphaseiandiiopenlabelstudyontheimmunomodulatoryeffectsofseaweedextractnutrientcomplex AT etal combinedphaseiandiiopenlabelstudyontheimmunomodulatoryeffectsofseaweedextractnutrientcomplex |
| _version_ |
1718402493334945792 |